Skip to content

Manual Compared to Magnetic Navigation in Ablation for Atrial Fibrillation

Manual Compared to Magnetic Navigation in Ablation for Atrial Fibrillation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01407588
Enrollment
51
Registered
2011-08-02
Start date
2011-08-31
Completion date
2017-02-28
Last updated
2017-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Atrial fibrillation, Ablation

Brief summary

The purpose of this study is to compare manual and magnetic navigation in ablation for atrial fibrillation.

Interventions

PROCEDUREMagnetic navigation

Ablation with use of the magnetic navigation system

PROCEDUREAblation performed with manual navigation

Atrial fibrillation ablation performed with manual navigation

Sponsors

St. Olavs Hospital
CollaboratorOTHER
SINTEF Health Research
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Undergoing ablation for atrial fibrillation at St. Olavs Hospital * Implanted Reveal

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with recurrence of atrial fibrillation after ablation2 yearsIf the patient have had recurrence or not of atrial fibrillation after ablation. An implanted arrhythmia loop recorder (Reveal XT) is used for monitoring. Recurrence is defined as an attack of atrial fibrillation of more than 2 minutes. It will also be specified if the patient is referred for a second ablation procedure.

Secondary

MeasureTime frameDescription
Number of Participants with Adverse Events as a Measure of Safety and TolerabilityDay 1(after ablation procedure)Complications during and after the ablation procedure. Major: pericardial tamponade, permanent atrioventricular (AV) block, major bleeding, cerebral embolus, infection, heart failure, death. Minor: minor bleeding and temporary AV block.
Exposure of radiation to health personnel involved in the procedureDay 1(after ablation procedure)Total time with use of of radiation equipment. Radiation exposure of the operator.
Amount of analgetics and sedatives given during procedureDay 1As a measure of pain and discomfort experienced by the patient during the procedure, the amount of medications are assessed
PainAfter ablation(day 1)Pain scores on the Visual Analog Scale
Numbers of and types of catheters usedDuring ablation(Day1)As a measure of resources needed for the procedure, the catheters used are registered. Numbers of and type of catheters are registered and total cost calculated.
Procedure timeDay 1(after ablation procedure)Duration of the ablation procedure
Total time nurses are occupied with the ablationDuring the ablation(day 1)As a measure of cost and resources needed for the procedure
Myocardial damageAfter ablation(day 1)Measured by Troponin-t and CK-MBAs
Cardiac volumes and function1 yearMeasured by echocardiography
Quality of life2 yearsMeasured by SF-36 and atrial fibrillation symptoms and severity checklist
Time with active ablationDuring the procedure(Day 1)Total time that electrical current has been used during the ablation

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026